Literature DB >> 23720784

Down-regulation of miR-218-2 and its host gene SLIT3 cooperate to promote invasion and progression of thyroid cancer.

Hongyu Guan1, Gouhong Wei, Jueheng Wu, Donghong Fang, Zhihong Liao, Haipeng Xiao, Mengfeng Li, Yanbing Li.   

Abstract

CONTEXT: The functional relationships between intronic microRNAs (miRNAs) and their host genes in thyroid cancer remain unclear. miR-218, a miRNA down-regulated in several kinds of cancers and associated with multiple cancer phenotypes, is transcribed from 2 loci located on chromosomes 4p15.31 (miR-218-1) and 5q35.1 (miR-218-2) within the introns of SLIT2 and SLIT3, respectively.
OBJECTIVE: The aim of our work was to investigate the expression and the roles of miR-218-1 and miR-218-2, as well as their host genes SLIT2 and SLIT3 in thyroid carcinogenesis.
DESIGN: The expression of miR-218-1 and miR-218-2, as well as their host genes SLIT2 and SLIT3, in a panel of normal and neoplastic human thyroid tissues was assessed by quantitative RT-PCR. We restored the expression of miR-218-2 and SLIT3 in thyroid cancer cells and evaluated their effects on cell invasion, migration, and proliferation.
RESULTS: We found that miR-218-2 and its host gene SLIT3 were down-regulated concomitantly in thyroid cancer. Synergistic inhibitory effects of miR-218-2 with SLIT3 on thyroid cancer cell invasion, migration, and proliferation were observed. Moreover, the effects of miR-218-2 on thyroid cancer cells were due, at least partially, to targeting PDGFRA and PLCG1.
CONCLUSIONS: These results implicate the involvement of miR-218-2 and its host gene SLIT3 in thyroid cancer cell invasion, migration, and proliferation. Our findings highlight the functional associations of intronic miRNAs and their host genes in thyroid carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23720784     DOI: 10.1210/jc.2013-1053

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  43 in total

1.  MiR-491-5p negatively regulates cell proliferation and motility by targeting PDGFRA in prostate cancer.

Authors:  Yanjun Xu; Rui Hou; Qijie Lu; Yang Zhang; Lei Chen; Yuanyi Zheng; Bing Hu
Journal:  Am J Cancer Res       Date:  2017-12-01       Impact factor: 6.166

2.  MicroRNA-218 inhibits gastrointestinal stromal tumor cell and invasion by targeting KIT.

Authors:  Rong Fan; Jie Zhong; Sichang Zheng; Zhengting Wang; Ying Xu; Shuyi Li; Jie Zhou; Fei Yuan
Journal:  Tumour Biol       Date:  2013-12-29

3.  Genetic variation predicts serum lycopene concentrations in a multiethnic population of postmenopausal women.

Authors:  Niha Zubair; Charles Kooperberg; Jingmin Liu; Chongzhi Di; Ulrike Peters; Marian L Neuhouser
Journal:  J Nutr       Date:  2014-12-03       Impact factor: 4.798

4.  Feedback circuitry between miR-218 repression and RTK activation in glioblastoma.

Authors:  Lijoy K Mathew; Peiwei Huangyang; Vera Mucaj; Samuel S Lee; Nicolas Skuli; T S Karin Eisinger-Mathason; Kevin Biju; Bo Li; Sriram Venneti; Priti Lal; Justin D Lathia; Jeremy N Rich; Brian Keith; M Celeste Simon
Journal:  Sci Signal       Date:  2015-05-05       Impact factor: 8.192

5.  Comprehensive gene and microRNA expression profiling reveals a role for miRNAs in the oncogenic roles of SphK1 in papillary thyroid cancer.

Authors:  Weiwei Liang; Zhiwei Xie; Weiling Cui; Yan Guo; Lijuan Xu; Jueheng Wu; Hongyu Guan
Journal:  J Cancer Res Clin Oncol       Date:  2016-12-10       Impact factor: 4.553

6.  microRNA-218 suppresses the proliferation, invasion and promotes apoptosis of pancreatic cancer cells by targeting HMGB1.

Authors:  Zhe Liu; Yuanhong Xu; Jin Long; Kejian Guo; Chunlin Ge; Ruixia Du
Journal:  Chin J Cancer Res       Date:  2015-06       Impact factor: 5.087

7.  Down-regulation of miR-144 promotes thyroid cancer cell invasion by targeting ZEB1 and ZEB2.

Authors:  Hongyu Guan; Weiwei Liang; Zhiwei Xie; Hai Li; Juan Liu; Liehua Liu; Lingling Xiu; Yanbing Li
Journal:  Endocrine       Date:  2014-06-27       Impact factor: 3.633

8.  MiR-218 inhibits multidrug resistance (MDR) of gastric cancer cells by targeting Hedgehog/smoothened.

Authors:  Xiang-Liang Zhang; Hui-Juan Shi; Ji-Ping Wang; Hong-Sheng Tang; Shu-Zhong Cui
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

9.  Transmembrane protease serine 4 promotes thyroid cancer proliferation via CREB phosphorylation.

Authors:  Hongyu Guan; Weiwei Liang; Juan Liu; Guohong Wei; Hai Li; Lingling Xiu; Haipeng Xiao; Yanbing Li
Journal:  Thyroid       Date:  2015-01       Impact factor: 6.568

10.  MicroRNA-218 inhibits the migration, epithelial-mesenchymal transition and cancer stem cell properties of prostate cancer cells.

Authors:  Bing Guan; Lijun Mu; Linlin Zhang; Ke Wang; Juanhua Tian; Shan Xu; Xinyang Wang; Dalin He; Yuefeng Du
Journal:  Oncol Lett       Date:  2018-06-01       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.